14 - 17 May, 2024
TIDES USA
Boston, MA, USA
Each year, the TIDES conference scientific agenda includes 150+ of the industry's top scientists to present the latest science and industry updates across the entire spectrum from discovery, preclinical, clinical development through CMC, Manufacturing and commercialization of therapeutics and vaccines for oligos, peptides, mRNA and genome editing products.
14 - 16 May, 2024
R&D Procurement & Sourcing in Pharma Summit
Boston, MA, USA
Strengthening supplier and internal stakeholder collaborations, innovating in- and outsourcing models, and adopting advanced technologies to streamline development cycle are key to achieving speed-to-patients and capital efficiency – and this is what the 8th R&D Procurement & Sourcing in Pharma Summit will bring to the table in 2024.
br>
Growing with this community over the last 8 years, the summit remains the definitive community for 100+ R&D Preclinical, Clinical Procurement, Sourcing, Category Management leaders from the likes of Takeda, Eli Lilly, Sarepta, Moderna, Jazz Pharmaceuticals, and Gilead to benchmark best practice, network and seek inspirations.
br>
Unlock the benefits of our 3-day summit with dedicated preclinical and clinical tracks. Gain insights from 20+ real-life stories on AI and machine learning applications, supplier chain resilience, clinical cost control, and contractual lifecycle and risk management. Accelerate drug development with a focus on agility and quality, delivering better drugs to patients faster.
15 - 16 May, 2024
PDA Good Aseptic Manufacturing Conference
Stuttgart, Germany
PDA Good Aseptic Manufacturing Conference 2024 scheduled to take place on 15-16 May 2024 in Stuttgart, Germany.
This year's conference will revolve around the theme Assessing EU GMP Annex 1: 264 days into the journey, providing a valuable platform to assess our experiences, identify gaps, process challenges, and explore unresolved questions.
Together, we will delve into the impact of this regulatory change, discussing its implications, but also opportunities for the aseptic manufacturing industry. Our primary objective is to facilitate open and constructive discussions among manufacturers, regulators, and experts from various fields. By sharing our experiences and insights, we aim to collectively address the remaining uncertainties and pave the way for further progress in this critical area.
In addition to evaluating the current situation, we want to encourage forward-thinking and explore future disruptive technologies. Let us collectively imagine a world where risks are minimized to the greatest extent possible. Together, we can shape the future of aseptic manufacturing and contribute to safer products for patients worldwide.
We cordially invite you to be a part of this exceptional event, joining us in Stuttgart for two days of in-depth discussions, networking opportunities, and knowledge exchange. Together, we can create a collaborative and inspiring atmosphere that fosters innovation and drives the industry forward.
21 - 23 May, 2024
15th Global Drug Delivery & Formulation Summit
Berlin, Germany
This May marks the return of the leading summit on drug delivery, formulation, and device development!
Participate in a 3-day event where top-notch experts engage in discussions about the most recent advancements in the industry, presenting case studies and sharing invaluable expertise.
With nearly 100 sessions, 4 distinct content streams, and designated networking breaks, this event provides an ideal platform to exchange innovative ideas, stay abreast of the latest industry trends, and address prevalent challenges.
3 - 4 June, 2024
euroPLX 85 Dublin
Dublin, UK
This 85th Marketplace is an exchange for licenses, products, assets, distribution deals and other Pharma Business Opportunities ranging from prescription to OTC drugs, companion diagnostics, nutraceuticals, and medical devices.
Flexible Partnering: Have an unlimited number of meetings with partners of your choice, either in-person at the venue or virtual during the video days before and after the event. Or arrange a face-to-face meeting plus an unlimited number of one-hour video meetings with the same person or company. Or reschedule a fixed event meeting to a video meeting anytime during the video days before and after the event should you be unable to attend.
4 - 6 June, 2024
2nd Next Gen Inhalation Delivery Summit
Boston, USA
In an era marked by remarkable advancements, the inhalation therapy field is rapidly evolving. From Avalyn's $175 million investment in inhaled pulmonary fibrosis trials to Krystal Biotech's FDA clearance for inhaled gene therapy and MIT engineers' work on inhaled nanoparticles, the field is abuzz with new advances and breakthroughs in inhalation delivery.
Right now, we explore inhaled therapies as an opportunity to re-purpose modalities to tackle unmet clinical need in diseases like COPD, asthma, IPF, emphysema, and lung cancer, to unlock therapeutic efficacy. Now is the time for the industry to unite and innovate solutions to challenges surrounding particle engineering, stability, and formulation-device compatibility. Immerse yourself in a wealth of knowledge at the 2nd Next Gen Inhalation Delivery Summit, as the only forum offering cutting edge, future focused updates for inhaled delivery of complex biologics, maintaining formulation integrity to achieve precise lung delivery.
This is the premier forum dedicated to inhalation's future, providing crucial insights and networking opportunities. Join us in June to stay ahead in optimizing lung-specific drug delivery for maximum efficacy and potency in non-invasive, localized delivery.
10 - 11 Juin, 2024
Prefilled Syringes West Coast
SAN DIEGO, USA
SAE Media Group’s 8th Annual Pre-Filled Syringes West Coast Conference will be back for 2024 in the West Coast to bring together device developers, biotech and big pharma. This year’s conference will explore the exciting advances in the combination product drug delivery space and a future outlook exploring how pharma, device developers and regulators can work together to encourage innovation.
As part of SAE’s leading injectable drug delivery conferences this is a must attend event; not only will the conference bring you key insights to enhance your drug device portfolio, but it will also give you the opportunity to network with key industry players. We hope to welcome you in June 2024!
24 - 25 June, 2024
2024 PDA Advanced Therapy Medicinal Products Conference
Amsterdam, The Netherlands
Join us on 24-25 June 2024, in Amsterdam, The Netherlands, for an enriching experience. Organized by the PDA and the Scientific Program Planning Committee, this conference, themed "Next Steps in AMTPs and Beyond", promises a comprehensive exploration of the latest developments in advanced therapy medicinal products.
With thousands of therapies currently in development across hospitals, start-ups, and pharmaceutical manufacturing portfolios, the common goal is to successfully bring these therapies to market. However, this journey is laden with challenges, including regulatory requirements, manufacturing options, costs, and sustainability concerns. The PDA Advanced Therapy Medicinal Products Conference has been a steadfast supporter of this path for many years.
Our program will be designed to feature diverse sessions covering cutting-edge topics, discussions with authorities, and intensive exchanges during question-and-answer sessions and breaks. Explore system solutions in the Exhibition area and engage in enlightening poster sessions.
26 - 27 June, 2024
2024 PDA Virus Conference
Amsterdam, The Netherlands
The Implementation of the newly published ICH Q5A into practice is a topic that all of the biopharmaceutical industry is eagerly discussing. Four main areas have been significantly updated in the new revision which has a major impact on the viral safety strategies for biological products. The revision expands the possibility of using prior knowledge for validation of viral clearance. The scope of the new ICH Q5A has been extended to cover new, advanced therapy, product types such as certain viral vectors (along with their helper viruses used at vector production). The implementation of virus safety principles in continuous manufacturing processes highlights a number of unique challenges which are discussed in new chapters of the guideline. One of the most significant changes in the new revision is the acknowledgment and implementation of advanced technologies such as next-generation sequencing and PCR for virus detection and the potential use of these technologies for replacing commonly used in vivo and in vitro adventitious agent tests.
27 - 28 June, 2024
RESCON EUROPE 2024
Barcelona, Spain
RESCON Europe is a prestigious and highly anticipated event that builds on the success of its previous editions in New York. Dedicated to Inhalation & Respiratory Drug Delivery | Connected Devices, it brings together leading experts from the pharmaceutical, biotechnology industry, and academia. The conference showcases cutting-edge innovations, emerging trends, and the latest advancements in respiratory drug delivery, aerosol science, device design, and digital applications. It offers a valuable platform for knowledge exchange, networking, and shaping the future of inhalation and respiratory therapeutics.
27 - 28 June, 2024
Injecta Summit 2024
Barcelona, Spain
InjectaSummit is the premier event uniting professionals from the pharmaceutical, medical device, and healthcare sectors in an exploration of the latest advancements in pre-filled syringes, injectable drug devices, and parenteral systems. Our summit is a vital hub for industry experts, decision-makers, and innovators to exchange insights, discuss regulatory compliance, delve into patient-centric design, explore emerging technologies, and address sustainability. It’s where professionals learn, network, and collaborate with leaders in these fields. Join us in beautiful Barcelona on June 27-28, 2024, and be part of the conversation that’s shaping the future of injectable drug delivery.
25 - 27 June, 2024
13th HPAPI: Process Development for Highly Potent Drugs Summit
Philadelphia, PA, USA
The rise in novel, more potent compounds, alongside EU Annex 1, are mounting pressure on biopharma, CDMOs and equipment providers to evolve their industrial hygiene, process engineering and manufacturing capabilities to ensure safe handling and effective scale-up to achieve commercial GMP manufacturing. The 13th HPAPI: Process Development for Highly Potent Drugs Summit is your definitive community to evaluate efficient high potent compounds synthesis, adoption of innovative technology platforms and occupational safety best practice.
Built on 12 years, this is your must-attend summit to network with 130+ like-minded individuals to
- Expedite safe, efficient clinical and commercial manufacturing of novel high potent drugs
- Explore and validation new containment solutions and technologies to optimize process development and manufacturing
- Increase your multi-product facility flexibility through robust design, and mitigate cross contamination with cleaning validation
- Effectively implement bullet-proof risk assessment of occupational exposure, and reporting system to comply with EU Annex 1
